Institute of Pathology and Neuropathology, University Hospital and Comprehensive Cancer Center Tuebingen, Tuebingen, Germany.
J Pathol. 2024 Jul;263(3):271-274. doi: 10.1002/path.6294. Epub 2024 May 22.
Follicular lymphoma (FL) is an indolent B-cell neoplasm characterised by multistep evolution from premalignant precursor cells carrying the hallmark t(14;18) translocation in the majority of cases. In a new article in The Journal of Pathology, samples of relapsed early-stage FL - primary manifestation and relapse with or without transformation - initially treated with radiotherapy only, were studied for clonal relationships and evolution. Using somatic mutations and the rearranged immunoglobulin sequences as markers, the majority of paired lymphoma samples showed so-called branched evolution from a common, possibly premalignant progenitor cell, with both shared and private mutations. In addition, clonally unrelated cases were identified. This and previous studies with similar findings clearly document that relapse or transformation of FL in many instances not necessarily represents a linear progression of disease due to acquisition of additional mutations and therapy resistance, but rather new outgrowths derived from a pool of clonally related, long-lived, and low proliferating precursor cells, or even unrelated second neoplasms. © 2024 The Authors. The Journal of Pathology published by John Wiley & Sons Ltd on behalf of The Pathological Society of Great Britain and Ireland.
滤泡性淋巴瘤(FL)是一种惰性 B 细胞肿瘤,其特征是大多数情况下,从携带标志性 t(14;18)易位的恶性前体细胞经历多步进化。在《病理学杂志》的一篇新文章中,研究了最初仅接受放疗治疗的复发早期 FL(原发性表现和复发伴或不伴转化)的样本,以研究克隆关系和演变。使用体细胞突变和重排的免疫球蛋白序列作为标记,大多数配对的淋巴瘤样本显示出所谓的从共同的、可能是恶性前体细胞的分支进化,既有共享的突变,也有私有突变。此外,还鉴定了克隆无关的病例。这和以前的具有类似发现的研究清楚地证明,在许多情况下,FL 的复发或转化不一定代表由于获得额外的突变和治疗耐药性而导致疾病的线性进展,而是来自克隆相关的、长寿的、低增殖的前体细胞池的新生长,甚至是无关的第二肿瘤。© 2024 作者。《病理学杂志》由 John Wiley & Sons Ltd 代表英国和爱尔兰病理学学会出版。